← Back to Search

Parent Education for Gross Motor Delay in Children

N/A
Waitlist Available
Led By Nathalie Maitre, MD, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to week 9
Awards & highlights

Study Summary

This trial will test whether an educational intervention delivered through social media can help improve parents' understanding of their child's development and progress towards developmental goals. A secondary objective is to see if this intervention can also improve parent-related outcomes, like satisfaction with the program and parenting attitudes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to week 9
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to week 9 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Child Development Goals
Change in Child Development Understanding Score
Change in Developmental Assessment of Young Children - Second Edition (DAYC-2) Gross Motor Subdomain Score
Secondary outcome measures
Change in Mother-to-Infant Bonding Scale (MIBS) Score
Change in Parenting Stress Index, Fourth Edition Short Form (PSI-4-SF) Score
Change in Perceived Maternal Parenting Self-Efficacy (PMP S-E) Score
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Parent Educational ProgramExperimental Treatment1 Intervention
Caregivers of children with gross motor delays who are randomized to receive an educational intervention delivered through social media.
Group II: Control GroupActive Control1 Intervention
Caregivers of children with gross motor delays who are randomized to the waitlist control group who will receive an educational intervention delivered through social media after a 9 week waiting period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Parent Educational Program
2022
N/A
~100

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,638 Previous Clinical Trials
2,560,440 Total Patients Enrolled
Nathalie Maitre, MD, PhDPrincipal InvestigatorEmory University
1 Previous Clinical Trials
267 Total Patients Enrolled

Media Library

Parent Educational Program Clinical Trial Eligibility Overview. Trial Name: NCT05542251 — N/A
Gross Motor Delay Research Study Groups: Parent Educational Program, Control Group
Gross Motor Delay Clinical Trial 2023: Parent Educational Program Highlights & Side Effects. Trial Name: NCT05542251 — N/A
Parent Educational Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05542251 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the key goals this research is attempting to achieve?

"The primary endpoint of this study will be a Change in Child Development Goals, measured at Baseline and Week 9 post-intervention. Secondary outcomes include the Satisfaction with Intervention (which is evaluated qualitatively), Change in Mother-to-Infant Bonding Scale Score, and Change in Perceived Maternal Parenting Self-Efficacy Score."

Answered by AI

Is this research project currently searching for participants?

"This clinical trial, which was initially announced on the 28th of September 2022 is currently looking for potential participants. The details were last revised two days ago (30/09/2022)."

Answered by AI

How many participants are involved in this research endeavor?

"Affirmative. According to the clinicaltrials.gov page, this research trial was first published on September 28th 2022 and is currently accepting participants.130 individuals are needed from 3 different medical facilities for enrolment in the study."

Answered by AI
~37 spots leftby Apr 2025